What's next in Medicare drug negotiations?

On Tuesday, the White House unveiled a list of prescription drugs that Medicare will start negotiating prices with manufacturers. Part of the Inflation Reduction Act, the move isn't without controversy and legal challenges. Bloomberg Law's Nyah Phengsitthy joins Jim to explain why it's a long way from a done deal.